DCK and cancer: One recent study demonstrated that ROS detoxification and microRNA (miR)‐155 suppressed post‐transcriptional dCK levels, leading to chemoresistance in pancreatic cancer cells.39 Post‐translational modifications also affect dCK enzymatic activity, regulate drug metabolism and contribute to drug resistance in cancer.